David Sinclair

369 papers receiving 46.2k citations

David Sinclair's Hit Papers

Human trials exploring anti-aging medicines 2024 · 106 citations
1060+5+10Years since publication2505007501000

Peers

David Sinclair
Comparison fields: 5 of 219
  • Geriatrics and Gerontology 17.8k
  • Aging 6.4k
  • Physiology 3.8k
  • Physiology 13.5k
  • Biological Psychiatry 934
Replace Claudio Franceschi with:
Claudio Franceschi Italy
Judith Campisi United States
Douglas R. Green United States
Joshua D. Rabinowitz United States
Steve Horvath United States
David B. Allison United States
Vamsi K. Mootha United States
Dean P. Jones United States
Richard A. Miller United States
Thomas F. Lüscher Switzerland
David Sinclair relative to Claudio Franceschi Italy Claudio Franceschi's profile →
Citations per field
00.5×6.3×
Claudio Franceschi · 1×
Citations per year

Countries citing papers authored by David Sinclair

Since Specialization
Citations

This map shows the geographic impact of David Sinclair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sinclair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sinclair more than expected).

Fields of papers citing papers by David Sinclair

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sinclair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sinclair. The network helps show where David Sinclair may publish in the future.

Co-authors

The 25 scholars most cited alongside David Sinclair, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Sinclair Line = papers co-authored together David Sinclair links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 382 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Therapeutic potential of resveratrol: the in vivo evidence
Hit paper breakdown →
20063154
2
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Hit paper breakdown →
20032984
3
Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase
Hit paper breakdown →
20042730
4
Mammalian Sirtuins: Biological Insights and Disease Relevance
Hit paper breakdown →
20101671
5
Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase
Hit paper breakdown →
20041587
6
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
Hit paper breakdown →
20041430
7
Sirtuins in mammals: insights into their biological function
Hit paper breakdown →
20071418
8
Extrachromosomal rDNA Circles— A Cause of Aging in Yeast
Hit paper breakdown →
19971175
9
Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging
Hit paper breakdown →
20131108
10
The Intersection Between Aging and Cardiovascular Disease
Hit paper breakdown →
20121072
11
SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis
Hit paper breakdown →
2007863
12
Inhibition of Silencing and Accelerated Aging by Nicotinamide, a Putative Negative Regulator of Yeast Sir2 and Human SIRT1
Hit paper breakdown →
2002832
13
Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell Survival
Hit paper breakdown →
2007796
14
The Ratio of Macronutrients, Not Caloric Intake, Dictates Cardiometabolic Health, Aging, and Longevity in Ad Libitum-Fed Mice
Hit paper breakdown →
2014692
15
Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
Hit paper breakdown →
2010686
16
Why does COVID-19 disproportionately affect older people?
Hit paper breakdown →
2020683
17
Molecular Biology of Aging
Hit paper breakdown →
1999669
18
SIRT1 Redistribution on Chromatin Promotes Genomic Stability but Alters Gene Expression during Aging
Hit paper breakdown →
2008649
19
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Hit paper breakdown →
2018616
20
Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds
Hit paper breakdown →
2016615

About David Sinclair

David Sinclair is a scholar working on Molecular Biology, Geriatrics and Gerontology, Physiology, Aging and Epidemiology, having authored 382 papers that have together received 47.3k indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (102 papers), Genetics, Aging, and Longevity in Model Organisms (53 papers), Adipose Tissue and Metabolism (50 papers), Autophagy in Disease and Therapy (27 papers), Mitochondrial Function and Pathology (25 papers), Calcium signaling and nucleotide metabolism (19 papers), Biochemical effects in animals (16 papers) and DNA Repair Mechanisms (16 papers). The work is most often cited by research in Geriatrics and Gerontology (17.8k citations), Aging (6.4k citations), Physiology (3.8k citations), Physiology (13.5k citations) and Biological Psychiatry (934 citations). David Sinclair has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Joseph A. Baur, Leonard Guarente, Haim Cohen, Shaday Michán, Marcia C. Haigis, Kevin J. Bitterman, Konrad T. Howitz, Jason G. Wood, Brian J. North and Siva Lavu. Their work appears in journals such as Cochrane Database of Systematic Reviews, Journal of Clinical Pathology, Cell, Annals of Clinical Biochemistry International Journal of Laboratory Medicine and Cell Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact